NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Napco Security Technologies, Inc. (NASDAQ: NSSC) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Napco Security caused the company to misrepresent Napco’s overall expected growth and strength in the Company’s hardware division, including, among other things, confidence in Napco’s ability to achieve i ...

Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by officers and directors of BigBear.ai Holdings, Inc. (NYSE: BBAI) towards shareholders [1] Group 1: Legal Investigation - A federal securities lawsuit alleges that insiders at BigBear.ai misrepresented or failed to disclose critical accounting issues, including deficient accounting review policies [2] - The lawsuit claims that BigBear incorrectly accounted for the 2026 Convertible Notes, failing to bifurcate the conversion option as required by accounting standards [2] - Due to these errors, BigBear's financial statements were inaccurate and may need to be restated, increasing the risk of delays in filing financial reports with the U.S. Securities and Exchange Commission [2] Group 2: Shareholder Action - Shareholders who purchased BBAI shares prior to March 31, 2022, are encouraged to contact Kuehn Law for potential legal action, as there may be limited time to enforce their rights [3] - Kuehn Law offers to cover all case costs and does not charge investor clients, emphasizing the importance of shareholder participation in maintaining market integrity [4]

NEW YORK, June 11, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Treace Medical Concepts, Inc. (NASDAQ: TMCI) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Treace Medical caused the company to misrepresent or fail to disclose (1) competition impacted the demand for and utilization of its primary product, the Lapiplasty 3D Bunion Correction System; (2) as a result, T ...

Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by certain officers and directors of ModivCare, Inc. related to misrepresentation of financial conditions and operational performance [1] Group 1: Legal Investigation - Kuehn Law is looking into whether ModivCare's insiders misrepresented or failed to disclose critical information regarding contracts in the non-emergency medical transportation (NEMT) segment [2] - The investigation focuses on claims that these misrepresentations led to a deterioration in the company's free cash flow and negatively impacted adjusted EBITDA due to contract renegotiations and pricing accommodations [2] Group 2: Financial Implications - The company reportedly faced insufficient liquidity as a result of the aforementioned issues, which raises concerns about its financial stability [2] - Positive statements made by the company regarding its business operations and future prospects were deemed materially misleading and lacked a reasonable basis [2]

Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by certain officers and directors of Axsome Therapeutics, Inc. related to misrepresentation of the company's practices and prospects [1] Group 1: Allegations of Misrepresentation - Insiders at Axsome allegedly caused the company to misrepresent or fail to disclose deficiencies in its chemistry, manufacturing, and control (CMC) practices concerning AXS-07 [2] - As a result of these deficiencies, Axsome was unlikely to submit the AXS-07 New Drug Application (NDA) on the initially represented timeline [2] - The unresolved CMC issues were present during the FDA's review of the AXS-07 NDA, leading to a low likelihood of FDA approval [2] - Consequently, Axsome overstated AXS-07's regulatory and commercial prospects, making the company's public statements materially false and misleading [2]